top of page

Drugs - Aug 2019

  • Writer: ARQon
    ARQon
  • Aug 30, 2019
  • 1 min read

Updated: Jan 8, 2020

  • China : NMPA No. 2019/34 Issuance of Provision n Drug Quality Inspection and and Testing

  • EU/US : EMA/FDA Analysis Shows High Degree of Alignment in Marketing Application Decisions Between EU and US.

  • South Korea : Five-year Master Plan for Clinical Trials Development

  • Thailand : Criteria and Conditions for Drug Dossier Registration Review, Draft version

Contact us at info@arqon.com.


Comments


bottom of page